Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 34, Issue 3, 2014, Pages 363-369

  Lv, Jun ^a,b   Ma, Ling ^a   Chen, Xi Lin ^a   Huang, Xiao Hui ^a   Wang, Qian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

AKT GSK 3 Cdc25A signaling pathway; hepatocellular carcinoma; invasion; LncRNAH19; migration; miR 675

Indexed keywords

CDC25A PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; H19 LONG NON CODING RNA; H19 LONG NON-CODING RNA; LONG UNTRANSLATED RNA; MICRORNA; MIRN675 MICRORNA, HUMAN; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CELL LINE; CELL MOTION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CDC25 PHOSPHATASES; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 84904023890     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-014-1284-2     Document Type: Article

References (33)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127(12):2893-2917
2. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 2006, 6(4):259-269
3. Huang S, He X. The role of microRNAs in liver cancer progression. Br J Cancer, 2011, 104(2):235-240
4. Wong QW, Ching AK, Chan AW, et al. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin Cancer Res, 2010, 16(3): 867-875
5. Yao J, Liang L, Huang S, et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology, 2010, 51(3): 846-856
6. Xia H, Ooi LL, Hui KM. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS One, 2012, 7(9):e44206
7. Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer? Hum Mol Genet, 2010, 19 (R2):152-161
8. Lai MC, Yang Z, Zhou L, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol, 2012, 29(3):1810-1816
9. Geng YJ, Xie SL, Li Q, et al. Large intervening non-coding RNAHOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res, 2011, 39(6): 2119-2128
10. Matouk IJ, DeGroot N, Mezan S, et al. The H19 non-coding RNA is essential for human tumor growth. PLoS One, 2007, 2(9):e845
11. Wu J, Qin Y, Li B, et al. Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma. Genomics, 2008, 91(5):443-450
12. Chen CL, Lp SM, Cheng D, et al. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer. Clin Cancer Res, 2000, 6(2):474-479
13. Nakagawa H, Chadwick RB, Peltomaki P, et al. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA, 2001, 98(2):591-596
14. Cai X, Cullen BR. The imprinted H19 noncoding RNA is a primary micro-RNA precursor. RNA, 2007, 13(3): 313-316
15. Wendel HG, De Stanchina E, Fridman JS, et al. Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy. Nature, 2004, 428(6980):332-337
16. Cross DA, Alessi DR, Cohen P, et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 1995, 378(6559):785-789
17. Kang T, Wei Y, Honaker Y, et al. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell, 2008, 13(1):36-47
18. Kristjánsdóttir K, Rudolph J. Cdc25 phosphatases and cancer. Chem Biol, 2004, 11(8):1043-1051
19. Du Y, Kong G, You X, et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus x protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem, 2012, 287(31): 26302-26311
20. Tsang WP, Ng EK, Ng SS, et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis, 2010, 31(3):350-358
21. Bartolomei MS, Zemel S, Tilghman SM. Parental imprinting of the mouse H19 gene. Nature, 1991, 351(6322): 153-155
22. Ayesh S, Matouk I, Schneider T, et al. Possible physiological role of H19 RNA. Mol Carcinog, 2002, 35(2): 63-74
23. Luo M, Li Z, Wang W, et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett, 2013, 333(2):213-221
24. Luo M, Li Z, Wang W, et al. Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J, 2013, 280(7):1709-1716
25. Hao Y, Crenshaw T, Moulton T, et al. Tumour-suppressor activity of H19 RNA. Nature, 1993, 365(6448):764-767
26. Zhang L, Yang F, Yuan JH, et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis, 2013, 34(3):577-586
27. Tripathi V, Shen Z, Chakraborty A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet, 2013, 9(3):e1003368
28. Blomberg I, Hoffmann I. Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Biol, 1999, 19(9):6183-6194
29. Molinari M, Mercurio C, Dominguez J, et al. Human Cdc25A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep, 2000, 1(1):71-79
30. Yang C, Li X, Wang Y, et al. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene, 2012, 496(1):8-16
31. Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol, 2001, 2(10):769-776
32. Puc J, Keniry M, Li HS, et al. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell, 2005, 7(2):193-204
33. Shtivelman E, Sussman J, Stokoe D. A role for PI3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr Biol, 2002, 12(11):919-924